Empagliflozin and Protecting Microvascular Support of Heart Mechanics: SGLT2 Inhibition or More?

JACC Basic Transl Sci. 2019 Sep 23;4(5):592-595. doi: 10.1016/j.jacbts.2019.08.003. eCollection 2019 Sep.
No abstract available

Keywords: cardiomyocyte; empagliflozin; endothelial cell; heart failure; microvasculature.

Publication types

  • Editorial
  • Comment